Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000Business Wire • 1 day ago
Pulse Biosciences, Inc. (Nasdaq: PLSE) (Pulse or the Company), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, today announced that the...
Share to Feed
In trading on Monday, shares of Pulse Biosciences Inc (PLSE) crossed below their 200 day moving average of 7.36, changing hands as low as 6.69 per share. Pulse Biosciences Inc shares are...
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript...
Pulse Biosciences Inc (PLSE) Q4 2023 Earnings Call Transcript...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pulse Biosciences just reported results for the fourth quarter of 2023.
The post PLSE Stock Earnings: Pulse Biosciences Reported Results...
Financial Highlights Reflect Development Progress and Cost ManagementRelated Stocks: PLSE...
Pulse Biosciences files for $50M mixed securities shelf...
Pulse Biosciences to initiate rights offering...
Pulse Biosciences to initiate rights offering...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...